Category Archives: Remdecivir

Gerard 2021; Remdesivir and acute renal failure: A potential safety signal from disproportionality analysis of the WHO Safety Database

This gallery contains 2 photos.

Clinical Pharmacology & Therapeutics, 109 (4), April 2021.   Gérard, Laurain, Fresse, Parassol, . . .  & Drici Remdesivir has been recently approved by the US FDA for emergency use for Covid although “data pertaining to its effectiveness and safety are … Continue reading →

More Galleries | Leave a comment

Schumann 2020: Immune-modulating drug MP1032 (Remdesivir) with SARS-CoV-2 antiviral activity in vitro: A potential multi-target approach for prevention and early intervention treatment of COVID-19

This gallery contains 2 photos.

International Journal of Molecular Sciences. 21(22):8803. This is a complex study of Remdesivir’s activity against the cytokine storm sometimes seen in cases of Covid-19. MP1032 (Remdesivir) is a reactive-oxygen scavenger (ROS) and was originally being developed to treat psoriasis, rheumatoid … Continue reading →

More Galleries | Leave a comment